Abstract
INTRODUCTION

52
Barrett's esophagus (BE) is a condition where normal squamous epithelium is replaced 53 by metaplastic columnar epithelium containing goblet cells. This condition is associated with a 54 40-fold increased risk for the development of esophageal adenocarcinoma (EAC) (14) . Now,
55
there is overwhelming evidence that BE arises as a consequence of chronic gastroesophageal 56 reflux disease (GERD) (19, 20) . Although the importance of GERD in the pathogenesis of BE is 57 undisputed, it is not yet clear which are the key elements in the refluxate responsible for 58 metaplastic change to intestinal epithelium (38) . In addition to gastric acid, also bile acids
59
(secreted into duodenum in response to a high-fat diet) are implicated in the development of BE 60 and EAC (9). It was shown that 22.2% of patients with esophagitis, 54.5% of patients with BE 61 and 78.6% of patients with EAC exhibit pathologic exposure to duodenal refluxate, indicating the 62 importance of bile acids in EAC pathogenesis (42).
63
Autophagy is a major physiological lysosome-dependent mechanism for degrading and 64 recycling cellular proteins and organelles (50). Basal levels of autophagy contribute to the 65 maintenance of intracellular homeostasis and is required for cell cleansing and remodeling (12).
66
Under conditions of starvation, the autophagic pathway supplies cells with metabolic substrates,
67
and represents a pro-survival mechanism. In response to stress, autophagy is important 68 mechanism to prevent the accumulation of damaged organelles and proteins. However, 
75
thus, considered a double-edged sword, since it is a tumor-suppression mechanism, but also it 76 enables survival of tumor cell during stress (32).
4
Beclin-1 has a central role in the regulation of autophagy in mammals (28). Autophagic 78 triggers upregulate Beclin-1, which in turn binds to class III phosphatidylinositol 3-kinase
79
(PI3KC3) and activates autophagosome formation and maturation. Beclin-1 acts as a tumor 80 suppressor in mammalian systems and the deletion of Beclin-1 was observed in various 81 cancers, including prostate, ovarian, breast, brain and lung cancers (30, 36) .
82
There are only limited studies on esophageal cancer and autophagy. It was shown that 
106
CP-AR cells resistant to cell death induced by DCA were developed from CP-A cells.
107
Initially, CP-A cells were initially grown in medium containing 0.02mM DCA for at least two 108 passages. As the cells became adapted, the concentration of DCA was increased by 0.02mM.
109
This procedure was repeated until the cells were able to survive and proliferate in medium with 110 0.2mM DCA. It took 15 weeks to achieve this resistance.
112
Patients
113
Sixty-two patients with known BE or EAC were included in the present study. 
187
Immunohistochemistry
188
The expression of Beclin-1 was determined in BE tissues with no dysplasia (BE), low 189 grade dysplasia (LGD), high grade dysplasia (HGD) EAC and in squamous epithelium by
190
immunohistochemistry as described previously (15). The Beclin-1 antibody was from ProSci
191
(2μg/ml, Poway, CA) A simple grading system (0-4) was employed to grade the level of Beclin-1 9 expression. Immunocontrol slides were prepared by replacing the primary antibody with rabbit
193
IgG at the same protein concentration as the primary antibody (2μg/ml). Staining was evaluated
194
independently by two experienced investigators. Beclin-1 in rat tissues was evaluated by 195 fluorescent microscopy as described previously (34).
196
For confocal microscopy, the cells were grown on 4-chamber slides, fixed with
197
formaldehyde and permeabilized with methanol as described previously (15). After blocking with
198
5% bovine serum albumin the cells were incubated overnight with antibodies against Beclin-1
199
(1:100, ProSci, Poway, CA). Next, Alexa Fluor®488 secondary antibodies (1:100, Molecular
200
Probes Inc., Eugene, OR) were applied for 60 minutes. The slides were counterstained with
201
propidium iodide (PI) and coverslipped using VectaShield HardSet medium (Vector
202
Laboratories, Burlingame, CA).
204
RT real-time PCR and microarray studies
205
To evaluate Beclin-1 mRNA expression in patient samples, total RNA from BE (N=18)
206
and EAC (N=6) was isolated using the Qiagen RNeasy Mini Kit (Valencia, CA) according to the 207 manufacturer's instructions. The isolated total RNAs were used to produce a labeled target,
208
hybridized to Affymetrix U133A GeneChips, and read using the Agilent/Affymetrix 2500A 209 scanner according to manufacturer's protocols as described previously (47).
210
Total RNA was isolated from different cell lines using the RNeasy Plus Mini Kit (Qiagen,
211
Santa Clarita, CA) as described in the manufacturer's protocol. RNA concentration and purity
212
was evaluated by NanoDrop (ThermoScientific, Wilmington, DE) at 260nm/280nm. RT real-time
213
PCR assays were performed to quantify mRNA levels of Beclin-1 as described previously (15). 
10
CAA-TAG-TGA-CCT-GGC-CGT-3'). 
242
Microarray analysis revealed that Beclin-1 mRNA is significantly decreased in EAC
243
(N=6) compared to BE (N=18, p<0.05, Figure 1A ). 
266
Lower levels of Beclin-1 were also detected in JH-EsoAD1 (Figure 3 
284
Confocal microscopy and Western blot analysis indicated that Beclin-1 expression was 285 increased after the exposure to DCA (Figure 5A , 6B). Beclin-1 expression was also increased 286 13 after the exposure to HBSS (positive control, Figure 5A ).
287
Next we assessed autophagy by evaluating the punctate pattern in cells transfected with
288
GFP-LC3 and transmission electron microscopy (TEM). DCA induces a significant increase in 289 the percentage of cells with punctate pattern, as does HBSS (positive control, Figure 5B Figure 5C ).
295
Chronic exposure to deoxycholic acid does not induce upregulation of Beclin-1
296
Since esophageal tissue is exposed to bile acids during reflux episodes we speculated that bile 297 acids may be responsible for activation of autophagy after acute exposure. However, after long-
298
term repeated exposure to bile acids, the tissues develop resistance to autophagic stimuli. To 
306
DCA was not present in the medium. Overall, the number of cells with GFP-LC3 punctate 307 pattern was elevated (31.6 ± 5.3%) in CP-AR cells compared to parental CP-A (14.9 ± 1.9 %).
308
However, treatment with 0.2mM DCA or HBSS for four hours did not result in any significant 309 increase of the GFP-LC3 positive cells with punctate pattern (26.0 ± 3.0% for DCA and 25.4 ± 310 5.8 % for HBSS, p>0.05, Figure 6C 
349
deficiency is also associated with increased angiogenesis (27).
16
The pattern of Beclin-1 expression in gastrointestinal carcinogenesis is not consistent.
351
Studies show that Beclin-1 and autophagy were suppressed in hepatocellular carcinoma (HCC)
352
and pancreatic cancer (13) 
364
In agreement with our studies conducted in human biopsies and in animal tissues,
365
studies on pancreatic cancer in rats showed that cells from pancreatic adenocarcinoma had 366 decreased autophagic activity compared to cells from premalignant nodules (45). These 367 observations suggest that autophagy is initially increased during premalignant stages of 368 carcinogenesis, and then decreased during the adenocarcinoma transition.
369
Because Beclin-1 expression was low in dysplastic BE, we wanted to determine if BE
370
tissue is sensitive/resistant to autophagic stimuli. Our data suggests that BE is resistant to 
17
The mechanism by which autophagy defects lead to accelerated tumorigenesis is not 
385
Bile acids are important in the etiology of gastrointestinal cancers including EAC, colon,
386
or pancreatic cancer (4, 5, 42) . During reflux episodes, the esophageal epithelium is exposed to 
423
In summary, the decreased Beclin-1 expression and resulting autophagy decrease after 424 chronic exposure to bile acids may lead to increased genomic instability and cancer
425
progression. 
594
Beclin-1 expression (green signal) in squamous epithelium, BE, EAC and negative control (NC).
595
DAPI was used as a nuclear counterstain (blue signal 
